Stock Information

Price $ 0
Change 0
Volume
Intraday High
Intraday Low
Today’s Open
0
$ 0
$ 0
$ 0
% Change
52 Week High
52 Week Low
Previous Close
0
$ 0
$ 0
$ 0

Stock Chart

Press Releases

Subscribe to our mailing list to receive the latest news.
To browse our press releases, simply click on the year that interests you to view the documents.

2020
Feb 13 - Neptune Officially Launches the Forest Remedies™ & Ocean Remedies™ Brands
Feb 13 - Neptune Reports Fiscal 2020 Third Quarter Results
Jan 30 - Neptune to Report Fiscal 2020 Third Quarter Financial Results on February 13, 2020
Jan 13 - Neptune Provides Updates on Non-Core Investments
Jan 10 - Neptune Provides Corporate Updates and Discusses 2020 Initiatives
2019
Nov 20 - Neptune Announces an Amended and Restated Agreement with Canopy
Nov. 11 - Neptune Announces a Definitive Agreement with International Flavors & Fragrances to Co-Develop Hemp-Derived CBD Products
Nov. 11 - Neptune announces Second Quarter Results
Oct. 28 - Neptune to Hold Conference Call to Discuss Second Quarter Results Ended September 30, 2019
Oct 17 - Neptune Signs an Extraction Agreement in the U.S. and Expands U.S. Sales Team
Oct 16 - Neptune Achieves a Milestone with Completion of Phase II Expansion
Oct 4 - Neptune Announces New Strategic Partnership with American Media LLC.
Oct 2 - Neptune announces strategic collaboration with IFF
Sept 24 - Neptune announces new US Customer Relations
Aug 22 - Neptune creates two new roles to support its expansion
Aug 15 - Neptune Announces the Election of its Directors and Voting Results
Aug 14 - Neptune announces First Quarter Results
July 29 - Neptune to Hold Conference Call to Discuss First Quarter Results Ended June 30, 2019
July 24 - Neptune Closes SugarLeaf Acquisition, Expanding U.S. Extraction Capabilities
July 18 - Neptune Wellness Solutions Closes US$41 Million Private Placement
July 8 - Neptune Appoints Michael Cammarata as Chief Executive Officer
June 17 - Neptune’s wholly owned subsidiary, 9354-7537 Québec Inc, Receives Health Canada’s Amendments to Expand Capacity to 200,000 kg and for Cannabis Oil Capsule Production
June 12 - Neptune Signs Multi-Year Extraction Agreement for 230,000 kg Including Turnkey Solutions with The Green Organic Dutchman
June 12 - Neptune Announces Fourth Quarter Results
June 7 - Neptune signs multi-year extraction agreement with Tilray
May 30 - Neptune to Hold Conference Call to Discuss Fourth Quarter and Fiscal Year-End Results Ended March 31, 2019
May 13 - Neptune Welcomes Martin Landry as Chief of Corporate Development & Strategy
May 10 - Neptune Settles On Claims on Employment Contract By Former Chief Executive Officer
May 9 - Neptune Signs definitive agreement to acquire the assets of Hemp processor SugarLeaf Labs
May 1 - Neptune to Present at May 2019 Conferences
Apr. 15 - Neptune Expands Existing Offering of Turnkey Solutions in the U.S. to Include Hemp Ingredients
Apr. 10 - Neptune Welcomes Dr. Graham Wood as Chief Scientific Officer
Apr. 4 - Neptune to present at 2019 GMP Securities Cannabis Conference
Mar. 26 - Neptune’s wholly owned subsidiary, 9354-7537 Québec Inc, Begins Commercial Production and Shipping of Cannabis Extracts
Mar. 25 - Neptune Receives Judgment On Claims By Former Chief Executive Officer
Feb. 13 - Neptune Annouces it Third Quarter Results
Jan. 29 - Neptune to Hold Conference Call to Discuss Third Quarter Results for the Three Months Period Ended December 31, 2018
Jan. 7 - Neptune’s wholly owned subsidiary, 9354-7537 Québec Inc., receives license to process cannabis from Health Canada
2018
Dec. 21 - Neptune to Expand Manufacturing Capability to Offer Cannabis Oil Capsules in Canada
Nov. 26 - Neptune to Participate in Fall 2018 Investor Conferences
Nov. 13 - Neptune Announces Second Quarter Results
Oct. 31 - Neptune to Hold Conference Call to Discuss Second Quarter Results for the Three Months Period Ended September 30, 2018 Laval,
Oct. 23 - Neptune to exhibit and present at 2018 Montreal Cannabis Expo
Sept. 27 - Appointment of Caroline Lavoie and Evidence package submitted to Health Canada
Sept. 20 - Neptune to Present at Sidoti & Company Fall 2018 Conference
Sept. 19 - Neptune Confirms its Name Change to Neptune Wellness Solutions Inc.
Sept. 17 - Neptune Receives Confirmation of Readiness Letter from Health Canada
Aug. 16 - Neptune Announces Appointment of Hélène F. Fortin to its Board of Directors
Aug. 15 - Neptune Announces the Election of its Directors and Voting Results
Aug. 14 - Neptune Announces First Quarter Results
Aug. 9 - Cannabis Patent Applications
Jul. 31 - Neptune to Hold Conference Call to Discuss First Quarter Results Ended June 30th, 2018
Jun. 19 - Neptune Announces Multi-year Agreement with Canopy Growth to Provide Extracted Cannabis Products
Jun. 5 - Neptune Announces Fourth Quarter and Year-end Results
Mar. 31 - Neptune to Hold Conference Call to Discuss Fourth Quarter and Fiscal Year-End Results Ended March 31, 2018
Feb. 14 - Neptune Announces Third Quarter Results
Feb. 12 - Neptune and Tetra Bio-Pharma Enter Co-Development Agreement for Purified Cannabinoid Oil-Based Products targeting Pain and Inflammation
Jan. 31 - Neptune to Hold Conference Call to Discuss Third Quarter Results for the Interim Period Ended December 31, 2017
Jan. 19 - Neptune Announces Research Agreement Aimed at New Medical and Wellness Cannabinoid-based Products
Jan. 17 - Neptune makes its recommendations on Bill 157 special consultations at the National Assembly
2017
Strength Sensei Nutraceuticals and Charles R. Poliquin launch MaxSimil®
Neptune Receives Nasdaq Notification Confirming that it has Regained Compliance with Minimum Bid Requirements
Highlights of Neptune’s Investor Conference Being Held in New York Today
Neptune Extends Global MaxSimil® Licence To Cannabis-Derived Products
Neptune Announces Second Quarter Results
Neptune to Hold Business Update Meeting on November 28, 2017
Neptune to Hold Conference Call to Discuss Second Quarter Results for the Interim Period Ended September 30, 2017
Neptune announces appointments for its Cannabis Business
Neptune to Hold Conference Call to Discuss the Transaction with Aker BioMarine
Aker BioMarine and Neptune announce closing of $US34 million transaction to accelerate business and industry development
Neptune Announces Resignation of Pierre Fitzgibbon as a Director and the Appointment of John Moretz as Chairman
Neptune Receives Nasdaq Notification Regarding Minimum Bid Requirements
Neptune to Hold Conference Call to Discuss First Quarter Results for the Three Months Period Ended June 30, 2017
Neptune Announces 4-Month Period and 13-Month Period Results
Neptune to Hold Conference Call to Discuss Fourth Quarter and Fiscal Year-End Results for the Thirteen Months Period Ended March 31, 2017
Unique Medical Cannabis Partnership Announced, Creating Scientific and Business Development Hub in Sherbrooke, Quebec
Neptune enters into Commercial Distribution Joint Venture in China with Shanghai Chonghe Marine Industry Co., Ltd.
Neptune and Enzymotec Reach Patent Agreement Ending All Litigation

Financial results

To browse our annual reports, simply click on the year that interests you to view the documents.

Annual and Quarterly Reports

2020
Neptune Financial Statements Q2 2019-2020
Neptune Quarterly Report Q2 2019-2020
Neptune Financial Statements Q3 2019-2020
Neptune Quarterly Report Q3 2019-2020
Neptune Quarterly Report Q1 2019-2020
Neptune Financial Statements Q1 2019-2020
2019
Management Information Circular 2019
Neptune Annual Information Form 2019
Neptune Quarterly Report Q4 2018-2019
Neptune Financial Statements Q4 2018-2019
Neptune Quarterly Report Q3 2018-2019
Neptune Financial Report Q3 2018-2019
Neptune Quarterly Report Q2 2018-2019
Neptune Financial Statements Q2 2018-2019
Neptune Quarterly Report Q1 2018-2019
Neptune Financial Statements Q1 2018-2019
2018
Proxy Circular 2018
Annual Information Form 2018
Neptune Financial Statements Q4 2017-2018
Neptune Quarterly Report Q4 2017-2018
Neptune Financial Statements Q3 2017-2018
Neptune Quarterly Report Q3 2017-2018
Neptune Financial Statements Q2 2017-2018
Neptune Quarterly Report Q2 2017-2018
Neptune Quarterly Report Q1-2017-2018
Neptune Financial Statements Q1-2017-2018
2017
Notice Of Meeting 2017
Proxy Circular 2017
Proxy Form 2017
Annual Information Form 2017
Neptune Financial Statements Q4 2016-2017
Neptune Quarterly Report Q4 2016-2017
Neptune Financial Statements Q3 2016-2017
Neptune Quarterly Report Q3 2016-2017
Neptune Financial Statements Q2 2016-2017
Neptune Quarterly Report Q2 2016-2017
Neptune Financial Statements Q1 2016-2017
Neptune Quarterly Report Q1 2016-2017
Events and Presentations

Neptune is committed to providing investors with timely and accurate information about our business strategy, operating performance and financial reporting. We participate in industry-sponsored conferences and events and also host conference calls and webcasts to review our financial and operating results.

Learn more
events
Neptune is driven by a passionate leadership team backed by years of industry experience and in-depth knowledge of pharmaceutical, biotech and nutritional supplements.
Learn More
Board of Directors Management Team
The Board of Directors leads, governs and sets Neptune's strategic direction.

Neptune is guided by an experienced group of professionals who believe that strong corporate governance is essential for delivering sustainable value and achieving the company’s vision and objectives.

Learn more
Board
Discover Neptune’s holistic approach to creating stakeholder value.
Learn more
nasdaq